#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	Q4R	NONSYN	10	12	CAG	260	262	CGG	17;18;19	C;G;G	17;18;19	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	S18T	NONSYN	52	54	TCC	302	304	ACC	18;17;16	A;C;C	18;17;16	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	S30A	NONSYN	88	90	TCG	338	340	GCG	15;15;17	G;C;G	15;15;17	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	N78E	NONSYN	232	234	AAT	482	484	GAA	24;23;23	G;A;A	19;19;17	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	P84L	NONSYN	250	252	CCG	500	502	CTG	21;21;21	C;T;G	21;19;21	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	N146V	NONSYN	436	438	AAC	686	688	GTC	25;26;27	G;T;C	25;26;27	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	P191L	NONSYN	571	573	CCT	821	823	CTT	30;32;30	C;T;T	30;32;30	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	Q220P	NONSYN	658	660	CAG	908	910	CCG	41;40;40	C;C;G	41;39;40	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	A274P	NONSYN	820	822	GCG	1070	1072	CCG	24;24;23	C;C;G	24;24;23	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_3__IIa.3002533.X13543.185_1046.620	AAC_3__IIa.3002533.X13543.185_1046.620	1	0	539	500	AAC_3__II-	861	861	97.1	AAC_3__II-.l15.c4.ctg.1	1267	21.2	0	.	p	.	0	I278V	NONSYN	832	834	ATC	1082	1084	GTC	21;22;22	G;T;C	21;21;22	.	AAC(3)-IIa is a plasmid-encoded aminoglycoside acetyltransferase in K. pneumoniae, E. cloacae, Actinobacillus pleuropneumoniae, S. typhimurium, Citrobacter freundii, and P. aeruginosa.;AAC(3)-IIa
AAC_6___IId.3002548.KC543497.1.404932_405451.3392	AAC_6___IId.3002548.KC543497.1.404932_405451.3392	1	0	27	422	AAC_6___Ib+	519	519	100.0	AAC_6___Ib+.l6.c4.ctg.1	1110	20.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(6')-IId is an integron-encoded aminoglycoside acetyltransferase in P. aeruginosa, E. cloacae, and C. freundii.;AAC(6')-IId
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	16	244	ANT_2____Ia	750	211	100.0	ANT_2____Ia.l15.c30.ctg.1	681	18.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii;ANT(2'')-Ia
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	756	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1261	32.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	405	407	ACG	39;36;35	A;C;G	39;36;35	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	L121Q	0	.	.	361	363	CTG	358	360	CTG	109;110;110	C;T;G	109;109;109	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	Q125E	0	.	.	373	375	CAG	370	372	CAG	111;112;112	C;A;G	110;110;112	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	Q125K	0	.	.	373	375	CAG	370	372	CAG	111;112;112	C;A;G	110;110;112	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	Q125R	0	.	.	373	375	CAG	370	372	CAG	111;112;112	C;A;G	110;110;112	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	Y161N	0	.	.	481	483	TAC	478	480	TAC	119;123;122	T;A;C	119;123;122	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	Y161D	0	.	.	481	483	TAC	478	480	TAC	119;123;122	T;A;C	119;123;122	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	Y161C	0	.	.	481	483	TAC	478	480	TAC	119;123;122	T;A;C	119;123;122	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	G317D	0	.	.	949	951	GGC	946	948	GGC	93;93;89	G;G;C,A	92;92;49,40	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1123	1125	GCA	66;64;64	G;C;A	61;62;63	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1123	1125	GCA	66;64;64	G;C;A	61;62;63	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1132	1134	GAA	58;57;58	G;A;A	58;56;58	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	1163	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1163	105.2	0	HET	.	.	.	C216T	.	216	216	C	213	213	C	95	C,T	55,39	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	206	19.6	1	SNP	p	A376S	0	.	.	1126	1128	GCA	13	15	GCA	17;18;18	G;C;A	6;7;7	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	206	19.6	1	SNP	p	A376V	0	.	.	1126	1128	GCA	13	15	GCA	17;18;18	G;C;A	6;7;7	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2646	Escherichia_coli_EF_Tu	1185	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	206	19.6	1	SNP	p	E379K	0	.	.	1135	1137	GAA	22	24	GAA	17;17;15	G;A;A	7;7;7	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1312	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1948	36.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1630	1632	AAA	28;26;25	A;A;A	28;26;25	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1522	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1880	43.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1304	1306	GAA	65;64;65	G;A;A	65;63;65	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	404	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	850	25.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
OXA_10.3001405.AF205943.7511_8312.878	OXA_10.3001405.AF205943.7511_8312.878	1	0	27	596	OXA_10+	801	801	100.0	OXA_10+.l15.c4.ctg.1	1373	23.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	OXA-10 is a beta-lactamase found in Acinetobacter baumannii and P. aeruginosa.;OXA-10
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	14	14	G	193	G	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	15	15	T	201	T	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	109	109	G	164	G	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	111	111	C	156	C	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	115	115	C	142	C	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	143	143	T	177	T	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	193	193	C	221	C	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	218	218	C	163	C	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	226	226	A	153	A	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	229	229	A	147	A	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	231	231	A	144	A	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	239	239	T	123	T	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	240	240	C	123	C	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	248	248	C	115	C	115	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	249	249	A	113	A	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	254	254	G	105	G	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	256	256	C	104	C	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	261	261	T	113	T	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	269	269	G	152	G	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	272	272	G	169	G	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	273	273	T	171	T,C	168,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	329	329	T	180	T,C	179,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	331	331	G	170	G	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	341	341	C	121	C	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	343	343	A	111	A	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	378	378	C	95	C	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	.1409C	INS	1409	1409	T	382	382	C	95	C	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	404	404	A	65	A	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	405	405	A	63	A	63	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	414	414	G	58	G	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	437	437	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	446	446	T	87	T	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	448	448	G	96	G	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	521	521	T	93	T	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	167	167	C	238	C	236	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4128	Pasteurella_multocida_16S	1551	524	91.62	Pasteurella_multocida_16S.l15.c30.ctg.2	574	174.8	0	HET	.	.	.	C1040T	.	1040	1040	T	13	13	C	168	C,T	69,38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1098	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1686	35.1	0	.	p	.	0	H2R	NONSYN	4	6	CAT	332	334	CGT	37;40;39	C;G;T	37;39;39	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1098	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1686	35.1	0	.	p	.	0	V30I	NONSYN	88	90	GTC	416	418	ATC	41;40;38	A;T;C	41;40;38	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1098	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1686	35.1	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1175	1177	GGC	50;49;49	G;G;C	50;48;49	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1636	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2119	41.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	282	284	AGC	32;31;35	A;G;C	32;31;35	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1636	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2119	41.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	684	686	CTA	45;46;45	C;T;A	45;46;45	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1636	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2119	41.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1203	1205	CAA	49;47;52	C;A;A	48;46;51	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1636	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2119	41.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1302	1304	GGT	51;49;48	G;G;T	50;49;48	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1636	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2119	41.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1872	1874	GTT	32;31;29	G;T;T	32;30;29	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1661	25.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	611	613	GAA	28;29;29	G;A;A	28;29;29	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1661	25.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	791	793	ACC	10;10;10	A;C;C	10;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1661	25.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	911	913	ACT	14;14;14	A;C;T	14;14;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1661	25.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1301	1303	ATC	10;10;11	A;T;C	10;10;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	990	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1556	34.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1116	aad-	789	789	100.0	aad-.l6.c4.ctg.2	1247	38.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2790	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3658	41.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	578	580	ATC	49;49;49	A;T;C	49;48;49	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2790	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3658	41.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2291	2293	AAG	40;39;41	A;A;G	40;38;41	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1150	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1729	35.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	343	345	GTC	29;27;28	G;T;C	29;27;28	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1150	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1729	35.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1084	1086	TGC	50;47;47	T;G;C	50;47;47	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2472	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3136	42.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	386	386	T	41	T	41	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2472	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3136	42.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	692	694	GAC	34;35;35	G;A;C	34;34;35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2472	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3136	42.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	968	970	TTA	22;22;22	T,G;T;A	21,1;21;21	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2472	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3136	42.1	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1151	1153	AAT	43;42;42	A;A;T	42;41;41	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2472	acrF	3105	2598	98.5	acrF.l6.c30.ctg.1	3136	42.1	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1938	1938	T	65	T	65	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	730	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1119	34.9	1	SNP	p	R45C	0	.	.	133	135	CGC	389	391	CGC	61;62;63	C;G,A;C	61;61,1;63	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	614	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1012	32.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	293	295	TTC	30;30;31	T;T;C,T	30;30;29,1	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	614	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1012	32.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	557	559	GGG	39;39;39	G;G;G	39;39;39	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	878	adiY	762	762	99.61	adiY.l6.c4.ctg.1	1298	36.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	666	668	CTT	56;56;55	C;T;T	55;56;55	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2530	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	3221	42.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2177	2179	GCA	68;68;69	G;C;A	68;67;69	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2530	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	3221	42.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2438	2440	ACC	47;49;51	A;C;C	45;49;51	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2530	alaS	2631	2631	98.86	alaS.l6.c4.ctg.1	3221	42.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2747	2749	GCC	48;48;46	G;C;C	48;48;46	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	438	440	GCT	6;7;9	G;C;T	6;7;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	558	560	GAG	21;19;18	G;A;G	21;19;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	594	596	TGC	22;22;23	T;G;C	22;22;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	777	779	GTT	22;22;22	G;T;T	22;22;22	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	927	929	CAC	29;29;28	C;A;C	29;29;28	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1212	1214	ATG	52;52;52	A;T;G	52;51;50	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1526	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2570	31.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2208	2210	CGC	27;26;24	C;G;C	26;26;24	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	672	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1343	26.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	950	952	ACC	27;26;26	A;C;C	26;26;26	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	672	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1343	26.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	962	964	TCG	34;35;39	T;C;G	34;35;39	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	546	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1147	25.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1104	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1878	31.5	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1357	1359	AAA	22;22;22	A;A;A	21;22;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1104	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1878	31.5	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1369	1371	GAG	22;23;25	G;A;G	22;21;25	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1104	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1878	31.5	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1375	1377	CAC	31;33;32	C;A;C	30;33;32	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1104	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1878	31.5	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1429	1431	GAG	26;25;25	G;A;G	26;25;25	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
blaTem.manually_added_GQ983346_ADN79103.1_1_861	blaTem.manually_added_GQ983346_ADN79103.1_1_861	1	0	155	1638	TEM_1+	861	861	100.0	TEM_1+.l15.c30.ctg.1	1176	72.9	0	HET	.	.	.	G304A	.	304	304	G	474	474	G	86	G,A	54,32	.	Original ref seq: GQ983346.1 Escherichia coli strain 1C plasmid beta-lactamase TEM-1 (blaTEM-1) gene, complete cds
blaTem.manually_added_GQ983346_ADN79103.1_1_861	blaTem.manually_added_GQ983346_ADN79103.1_1_861	1	0	155	1638	TEM_1+	861	861	100.0	TEM_1+.l15.c30.ctg.1	1176	72.9	0	HET	.	.	.	G706A	.	706	706	G	876	876	G	78	G,A	47,30	.	Original ref seq: GQ983346.1 Escherichia coli strain 1C plasmid beta-lactamase TEM-1 (blaTEM-1) gene, complete cds
catB3.manually_added_DQ321671_ABD04054.1_794_1426	catB3.manually_added_DQ321671_ABD04054.1_794_1426	1	0	27	406	catB-	633	633	100.0	catB-.l15.c4.ctg.1	959	22.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: DQ321671.1 Shigella sonnei plasmid pSS2852 multidrug-resistance class 1 integron, complete sequence
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1342	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1901	37.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	812	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1399	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	948	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1417	35.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	669	671	ACT	45;45;47	A;C;T	45;45;47	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	550	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	969	30.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1104	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1674	35.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	939	941	GTC	37;37;38	G;T;C	37;36;38	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1536	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2156	38.3	0	.	p	.	0	E197K	NONSYN	589	591	GAA	875	877	AAA	43;43;43	A;A;A	43;43;42	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1024	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1700	32.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	866	868	AGC	42;42;41	A;G;C	42;42;40	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	46	emrE_1	333	195	90.77	emrE_1.l15.c30.ctg.1	256	3.2	0	.	p	.	0	I100V	NONSYN	298	300	ATT	160	162	GTC	1;1;1	G;T;C	1;1;1	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	46	emrE_1	333	195	90.77	emrE_1.l15.c30.ctg.1	256	3.2	0	.	p	.	0	T108A	NONSYN	322	324	ACA	184	186	GCA	2;2;2	G;C;A	2;2;2	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	962	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1730	30.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	826	828	AGG	39;39;39	A;G;G	39;39;39	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	962	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1730	30.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1216	1218	GAC	33;33;33	G;A;C	33;33;33	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	622	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1093	30.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1564	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2098	40.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	562	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1150	26.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	394	396	CTG	27;27;26	C;T;G	27;27;26	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	380	382	ATA	26;26;24	A;T;A	26;26;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	392	394	GTA	20;19;19	G;T;A	20;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	545	547	ACG	23;23;25	A;C;G	23;23;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	608	610	GAA	22;23;23	G;A;A	22;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	647	649	GCT	20;21;22	G;C;T	20;21;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	665	667	GAT	16;15;15	G;A;T	16;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	752	754	TCA	20;20;22	T;C;A	20;20;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	881	883	CAG	22;22;22	C;A;G	22;21;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1019	1021	GTT	24;24;25	G;T;T	23;24;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1175	1177	GAT	13;12;12	G;A;T	13;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1343	1345	AAT	24;23;22	A;A;T	24;23;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1364	1366	TTA	11;11;11	T;T;A	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1565	1567	AAA	27;27;28	A;A;A	27;27;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2300	2302	CAT	23;25;26	C;A,T;T	23;24,1;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2354	2356	CAT	29;27;26	C;A;T	29;27;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2372	2374	AGA	31;31;31	A;G;A	30;31;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2387	2389	AAT	31;31;30	A;A;T	31;31;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2534	2536	TCC	22;22;21	T;C;C	22;22;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2699	2701	ATT	41;40;38	A;T;T	41;40;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2720	2722	GAT	43;44;41	G;A;T	43;44;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2834	2836	GTT	49;49;48	G;T;T	49;49;48	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2852	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4108	37.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3119	3121	CAC	62;62;60	C,G;A;C	61,1;61;60	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	930	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1356	36.8	1	SNP	p	P64A	0	.	.	190	192	CCA	453	455	CCA	63;63;63	C;C;A	62;61;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	930	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1356	36.8	1	SNP	p	P64H	0	.	.	190	192	CCA	453	455	CCA	63;63;63	C;C;A	62;61;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	930	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1356	36.8	1	SNP	p	P64S	0	.	.	190	192	CCA	453	455	CCA	63;63;63	C;C;A	62;61;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	930	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1356	36.8	1	SNP	p	P64L	0	.	.	190	192	CCA	453	455	CCA	63;63;63	C;C;A	62;61;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	930	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1356	36.8	1	SNP	p	P64R	0	.	.	190	192	CCA	453	455	CCA	63;63;63	C;C;A	62;61;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	546	gadE	528	528	100.0	gadE.l6.c30.ctg.1	1114	26.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	E54D	NONSYN	160	162	GAA	17	19	GAT	6;7;7	G;A;T	6;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	I88M	NONSYN	262	264	ATA	119	121	ATG	3;3;3	A;T;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	122	124	CCG	3;3;3	C;C;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	D100E	NONSYN	298	300	GAC	155	157	GAA	2;2;2	G;A;A	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	P101S	NONSYN	301	303	CCC	158	160	TCC	2;2;2	T;C;C	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	R102G	NONSYN	304	306	CGG	161	163	GGG	2;2;2	G;G;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	K110N	NONSYN	328	330	AAA	185	187	AAT	4;5;5	A;A;T	4;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	162	gadW	729	586	94.2	gadW.l15.c30.ctg.1	709	11.9	0	.	p	.	0	S234A	NONSYN	700	702	TCG	557	559	GCG	15;15;15	G;C;G	15;15;15	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	602	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1162	27.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	306	308	TTA	31;30;30	T;T;A	31;30;30	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	602	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1162	27.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	384	386	ATT	24;25;25	A;T;T	24;25;25	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	602	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1162	27.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	885	887	GGA	13;13;13	G;G;A	13;12;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	602	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1162	27.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	891	893	CCG	14;14;14	C;C;G	14;14;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	531	533	TTG	49;47;48	T,G;T;G	48,1;47;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2316	2318	GAA	46;49;49	G;A;A	46;49;49	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	1	SNP	p	D87G	0	.	.	259	261	GAC	543	545	GAC	47;47;48	G;A;C	47;46;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	1	SNP	p	D87N	0	.	.	259	261	GAC	543	545	GAC	47;47;48	G;A;C	47;46;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	1	SNP	p	D87H	0	.	.	259	261	GAC	543	545	GAC	47;47;48	G;A;C	47;46;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	543	545	GAC	47;47;48	G;A;C	47;46;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2530	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	3224	42.2	1	SNP	p	D87V	0	.	.	259	261	GAC	543	545	GAC	47;47;48	G;A;C	47;46;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136G	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136H	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136S	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136E	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136L	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136I	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2232	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2930	40.9	1	SNP	p	R136C	0	.	.	406	408	CGC	636	638	CGC	53;54;53	C;G;C	53;54;53	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	502	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1042	25.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	410	412	CCG	20;20;22	C;C;G	20;20;21	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	502	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1042	25.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	563	565	GCC	26;26;26	G;C;C	25;26;26	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	950	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1380	36.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	190	192	TCA	26;29;31	T;C;A	25;28;29	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	386	marA	384	384	99.74	marA.l15.c4.ctg.1	838	24.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	606	608	AGC	8;9;7	A;G;C	8;8;6	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	708	710	CAT	9;7;7	C;A;T	9;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	V45E	0	.	.	133	135	GTG	432	434	GTG	42;41;40	G;T;G	42;41;39	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	I49S	0	.	.	145	147	ATC	444	446	ATC	39;39;37	A;T;C	39;39;37	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	A70T	0	.	.	208	210	GCA	507	509	GCA	26;25;25	G;C;A	26;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	R73S	0	.	.	217	219	CGT	516	518	CGT	25;25;25	C;G;T	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	R73C	0	.	.	217	219	CGT	516	518	CGT	25;25;25	C;G;T	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	R77C	0	.	.	229	231	CGC	528	530	CGC	22;22;21	C;G;C	22;22;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	R77L	0	.	.	229	231	CGC	528	530	CGC	22;22;21	C;G;C	22;22;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	L78M	0	.	.	232	234	CTG	531	533	CTG	21;21;21	C;T;G	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	R94S	0	.	.	280	282	CGC	579	581	CGC	11;12;11	C;G;C	11;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	R94H	0	.	.	280	282	CGC	579	581	CGC	11;12;11	C;G;C	11;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	240	marR	435	435	97.7	marR.l15.c30.ctg.1	746	16.5	1	SNP	p	V96E	0	.	.	286	288	GTA	585	587	GTA	11;10;11	G;T;A	11;10;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	19	21	TTC	3;3;3	T;T;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	106	108	ATC	22;18;17	A;T;C	22;18;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	124	126	GCC	9;9;9	G;C;C	9;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	127	129	GTG	9;9;9	G;T;G	9;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	154	156	GAT	13;15;15	G;A;T	13;15;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	175	177	ACC	18;19;19	A;C;C	18;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	202	204	TTA	24;25;23	T;T;A	24;25;23	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	343	345	CAG	43;44;41	C;A;G	43;44;40	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	382	384	GCC	42;40;44	G;C;C	42;40;44	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	487	489	GCG	27;27;28	G;C;G	27;27;28	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	691	693	GTT	27;27;27	G;T;T	24;26;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	860	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1437	31.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	853	853	C	38	C	38	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	824	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1701	26.1	0	.	p	.	0	V12trunc	TRUNC	34	34	G	257	257	G	25	G	25	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	824	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1701	26.1	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	314	316	CAG	21;21;22	C;A;G	21;21;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	824	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1701	26.1	0	.	p	.	0	T83I	NONSYN	247	249	ACC	464	466	ATC	32;32;28	A;T;C	32;32;28	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	824	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1701	26.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	512	514	ATG	18;17;18	A;T;G	17;17;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	824	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1701	26.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	605	607	ACC	16;16;16	A;C;C	16;16;16	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	824	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1701	26.1	0	.	p	.	0	P257T	NONSYN	769	771	CCG	986	988	ACG	25;26;26	A;C;G	25;26;26	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1992	1994	ACC	54;51;53	A,T;C;C	51,1;50;52	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2385	2387	CAA	36;36;37	C;A;A	34;35;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2553	2555	ATT	56;56;57	A;T;T	56;56;57	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2637	2639	GTT	40;40;41	G;T;T	40;40;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2745	2747	GAG	32;31;32	G;A;G	32;31;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2973	2975	ATG	30;31;33	A,C;T;G	29,1;31;33	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2710	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3565	40.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3108	3110	GAT	34;34;35	G;A;T	34;33;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2458	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3331	39.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	342	344	ATG	25;25;24	A;T;G	23;24;23	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2458	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3331	39.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	828	830	ATC	47;48;49	A;T;C	47;47;49	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2458	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3331	39.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3144	3146	CAC	14;14;14	C;A;C	13;14;14	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2458	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3331	39.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3147	3149	CTC	14;14;12	C;T;C	14;13;12	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1240	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1886	35.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	216	218	GAA	20;19;19	G;A;A	20;18;19	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1240	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1886	35.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	885	887	GCG	41;41;43	G;C;G	40;40;43	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1240	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1886	35.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1227	1229	ATC	42;40;40	A;T;C	41;40;40	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1240	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1886	35.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1530	1532	TTT	48;49;46	T;T;T	47;49;46	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1216	mdtE	1158	1158	99.31	mdtE.l6.c4.ctg.1	1721	37.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2986	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3711	43.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1127	1129	ACC	44;42;41	A;C;C	44;41;41	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2986	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3711	43.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2369	2371	GAC	52;51;53	G;A;C	51;50;52	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1136	mdtG	1227	1047	99.33	mdtG.l6.c17.ctg.1	1678	29.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	689	691	ATC	44;44;45	A;T;C	44;44;45	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1136	mdtG	1227	182	99.45	mdtG.l6.c17.ctg.2	529	20.1	0	.	p	.	0	E5G	NONSYN	13	15	GAA	178	180	GGA	17;18;20	G;G;A	17;18;20	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	992	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1537	34.5	0	.	p	.	0	G134C	NONSYN	400	402	GGT	607	609	TGT	45;48;47	T;G;T	44;47;47	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	992	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1537	34.5	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1177	1179	TTG	51;49;48	T;T;G	51;49;48	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	992	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1537	34.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1387	1389	ACG	17;18;17	A;C;G	16;18;17	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1218	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1687	38.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	824	826	TCC	26;27;26	T;C;C	26;27;26	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	884	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1604	29.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	639	641	ATT	25;27;27	A;T;T	25;27;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	V11M	NONSYN	31	33	GTG	240	242	ATG	24;26;26	A;T;G	24;25;26	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	306	308	ATC	15;17;17	A;T;C	14;17;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	555	557	CGC	30;30;29	C;G;C	30;29;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	921	923	AGC	44;43;42	A;G;C	44;42;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1122	1124	GTG	38;38;39	G;T;G	38;35;38	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1185	1187	AAC	29;28;28	A;A;C	28;25;26	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1230	1232	GTC	38;37;36	G;T;C	37;36;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1260	1262	ATA	41;41;39	A;T;A	40;41;39	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1368	1370	TCT	41;43;42	T;C;T	41;43;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1755	1757	GCG	41;40;41	G;C;G	41;40;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1690	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2544	35.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1968	1970	ATC	35;35;35	A;T;C	35;35;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	607	609	GCG	40;41;38	G;C;G	40;40;37	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	781	783	ACC	38;38;39	A;C;C	38;38;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	853	855	CGC	50;48;47	C;G;C	49;47;47	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	970	972	GCT	35;34;36	G;C;T	35;34;35	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1054	1056	AAA	24;24;23	A;A;A	24;24;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1072	1074	CGA	28;27;27	C;G;A	28;27;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1237	1239	GCC	31;31;31	G;C;C	31;31;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1249	1251	GAT	39;40;41	G;A;T	39;40;41	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1182	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1909	33.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1666	1668	GCT	15;15;14	G;C;T	15;15;14	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3008	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3944	41.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1554	1556	AAG	29;30;31	A;A;G	29;30;31	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3008	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3944	41.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2631	2633	CTG	41;41;39	C;T;G	41;41;39	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	212	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	752	14.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1648	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2278	38.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1064	1066	AAC	33;33;33	A;A;C	33;33;33	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1648	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2278	38.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1610	1612	ATA	45;46;46	A;T;A	45;46;46	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1288	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1758	39.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1342	1344	GAT	64;64;64	G;A;T	64;62;64	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1288	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1758	39.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1345	1347	CTG	63;62;62	C;T;G	63;61;62	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	282	284	TGT	30;28;29	T;G;T	30;28;29	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	552	554	ACC	46;45;47	A;C;C	46;45;47	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	762	764	GAC	31;29;29	G;A;C	31;29;29	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	1	SNP	p	R15C	0	.	.	43	45	CGC	246	248	CGC	37;34;33	C;G;C	37;33;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	1	SNP	p	S33R	0	.	.	97	99	AGC	300	302	AGC	32;35;35	A;G;C	32;35;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	1	SNP	p	G131D	0	.	.	391	393	GGC	594	596	GGC	42;40;39	G;G;C	42;40;37	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	1	SNP	p	R203L	0	.	.	607	609	CGT	810	812	CGT	49;50;53	C;G;T,G	49;49;52,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	642	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1208	28.4	1	SNP	p	R203C	0	.	.	607	609	CGT	810	812	CGT	49;50;53	C;G;T,G	49;49;52,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1180	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1526	41.5	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1152	1154	GAG	54;56;56	G;A;G	54;56;56	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1180	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1526	41.5	1	SNP	p	G141D	0	.	.	421	423	GGT	639	641	GGT	55;56;58	G;G;T	55;56;57	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1180	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1526	41.5	1	SNP	p	G141E	0	.	.	421	423	GGT	639	641	GGT	55;56;58	G;G;T	55;56;57	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1180	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1526	41.5	1	SNP	p	R154D	0	.	.	460	462	CGT	678	680	CGT	54;52;49	C;G;T	53;51;48	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1180	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1526	41.5	1	SNP	p	R154A	0	.	.	460	462	CGT	678	680	CGT	54;52;49	C;G;T	53;51;48	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2772	44.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1934	1936	GTG	58;59;59	G;T;G	57;59;59	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2772	44.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1961	1963	TCG	62;62;66	T;C;G	59;60;64	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2772	44.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2576	2578	AAC	26;26;26	A;A;C	26;26;26	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2772	44.3	1	SNP	p	A85T	0	.	.	253	255	GCG	590	592	GCG	58;55;55	G;C;G	58;53;55	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2772	44.3	1	SNP	p	D111H	0	.	.	331	333	GAT	668	670	GAT	53;54;54	G;A;T	53;54;54	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2772	44.3	1	SNP	p	S129P	0	.	.	385	387	TCC	722	724	TCC	40;40;41	T;C;C	40;40;41	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1470	parE_1	1893	1893	97.52	parE_1.l6.c4.ctg.1	2493	31.7	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1712	1714	AAC	28;28;29	A;A;C	28;28;28	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1470	parE_1	1893	1893	97.52	parE_1.l6.c4.ctg.1	2493	31.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1721	1723	GAT	36;36;36	G;A;T	35;36;35	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1380	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1992	37.1	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	897	899	CAG	43;43;42	C;A;G	43;43;42	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1380	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1992	37.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1371	1373	GAT	48;49;48	G;A;T,A	48;49;47,1	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	V146F	0	.	.	436	438	GTT	680	682	GTT	53;52;51	G;T;T	53;52;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1781	1783	CAG	47;47;47	C;A;G	47;47;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1781	1783	CAG	47;47;47	C;A;G	47;47;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1820	1822	CAC	52;53;55	C;A;C	51;53;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1829	1831	CGT	57;55;51	C;G;T	57;55;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1829	1831	CGT	57;55;51	C;G;T	57;55;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1835	1837	TCC	53;54;52	T;C;C	53;54;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1841	1843	CTC	53;53;54	C;T;C	53;52;54	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1931	1933	ACC	71;71;73	A;C;C	70;71;73	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1934	1936	CCT	72;71;70	C;C;T	72;71;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4160	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4516	49.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2303	2305	CGT	69;71;69	C;G;T	69;71;67	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	516	358.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	226	A	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	516	358.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	226	A	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	516	358.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	226	A	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	.	n	.	0	A226G	SNP	226	226	A	413	413	G	380	G	377	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	1	SNP	n	A794G	0	.	.	794	794	A	981	981	A	365	A	361	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	1	SNP	n	A794T	0	.	.	794	794	A	981	981	A	365	A	361	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	1	SNP	n	G926C	0	.	.	926	926	G	1113	1113	G	346	G	346	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	1	SNP	n	G926A	0	.	.	926	926	G	1113	1113	G	346	G	346	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	1	SNP	n	G926T	0	.	.	926	926	G	1113	1113	G	346	G	346	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	A79G	.	79	79	A	266	266	A	338	A,G	249,87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	C719T	.	719	719	C	906	906	C	353	C,T	204,147	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	T273A	.	273	273	T	460	460	T	348	T,A	268,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	C183T	.	183	183	C	370	370	C	359	C,T	226,132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	A250T,G	.	250	250	A	437	437	A	339	A,T,G	262,70,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	T90C	.	90	90	T	277	277	T	341	T,C	256,82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	G474A	.	474	474	G	661	661	G	392	G,A	294,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	A253T	.	253	253	A	440	440	A	337	A,T	264,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1188	325.3	0	HET	.	.	.	C194T	.	194	194	C	381	381	C	371	C,T	296,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	70.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	120	A	119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	70.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	127	C	127	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	70.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	124	C	123	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	70.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	121	G	121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	70.0	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	122	G	122	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	70.0	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	123	T	123	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11838	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.6	143	100.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	694	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1086	34.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	536	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1089	26.3	1	SNP	p	R20H	0	.	.	58	60	CGC	373	375	CGC	45;47;46	C;G;C	45;47;45	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	536	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1089	26.3	1	SNP	p	G121D	0	.	.	361	363	GGT	676	678	GGT	43;42;44	G;G;T	43;42;43	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	442	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	902	26.0	1	SNP	p	A12S	0	.	.	34	36	GCA	267	269	GCA	58;57;58	G;C;A	58;57;58	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	512	36	APH_3____Ib+	804	225	98.67	APH_3____Ib+.l6.c4.ctg.2	226	3.0	0	.	p	.	0	D97V	NONSYN	289	291	GAT	211	213	GTT	1;1;1	G;T;T	1;0;1	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	512	36	APH_3____Ib+	804	225	98.67	APH_3____Ib+.l6.c4.ctg.2	226	3.0	0	.	p	.	0	L98W	NONSYN	292	294	TTG	214	216	TGG	1;1;1	T;G,T;G	1;0,1;1	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	512	36	APH_3____Ib+	804	147	100.0	APH_3____Ib+.l6.c4.ctg.3	147	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	16	46	APH_6__Id+	837	295	100.0	APH_6__Id+.l15.c30.ctg.1	295	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul1.manually_added_NC_002134_NP_052895.3_12192_13058	sul1.manually_added_NC_002134_NP_052895.3_12192_13058	1	0	27	438	sul1	867	867	100.0	sul1.l15.c4.ctg.1	1266	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_002134.1 Shigella flexneri 2b plasmid R100 DNA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	494	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1294	20.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	0	60	tetA	1200	223	100.0	tetA.l15.c30.ctg.1	223	3.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	0	60	tetA	1200	256	100.0	tetA.l15.c30.ctg.2	256	3.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	512	18	tetR	651	151	99.34	tetR.l6.c30.ctg.1	151	1.8	0	.	p	.	0	Y139F	NONSYN	415	417	TAC	103	105	TTC	2;1;1	T;T;C	1;0;0	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	512	18	tetR	651	157	100.0	tetR.l6.c30.ctg.2	157	1.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1532	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2146	38.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
